RLMD
Relmada Therapeutics Inc
NASDAQ · Pharmaceuticals
$3.88
+0.28 (+7.78%)
Analyst Consensus
Strong Buy
8 analysts
Price Target
Analyst Price Target
+863.1% upside
Low Target
$22.23
Average Target
$37.37
High Target
$43.38
Current Price
$3.88
Current
$3.88
$3.88
Target
$37.37
$37.37
$22.23
$37.37 avg
$43.38